InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Sebree Terri B, Présidente. Director active across 1 company, notably Zynerba Pharmaceuticals, Inc.. In total, 7 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €14k. Activity tracked since 26 January 2022. The latest transaction was filed on 23 January 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Sebree Terri B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
341,241 sharesCommon StockSEC:0001140361-23-047738:0
45,000 sharesCommon StockSEC:0001062993-23-018022:0
36,044 sharesCommon StockSEC:0000899243-23-004443:0
33,688 sharesCommon StockSEC:0000899243-23-003725:0
24,661 shares@ US$0.5978100.0% of flowCommon StockSEC:0001062993-23-001387:0
30,000 sharesCommon StockSEC:0001062993-22-016558:0
85,000 shares0Common StockSEC:0001062993-22-001778:0
7 of 7 declarations
About Sebree Terri B
Terri B. Sebree is the President of Zynerba Pharmaceuticals, Inc. In this role, she oversees the company's operations and is responsible for implementing the business strategy. Sebree plays a key role in directing and managing activities, ensuring that Zynerba meets its business objectives. Her experience in the pharmaceutical sector contributes to the organization's success.
